Member Info for DeAar

This is what it says in the first patient dosed RMS on the 6th June 2023 - "full safety data from this trial are expected to be available during the first half of 2024 and, provided satisfactory results are obtained, a Phase 1b clinical study is expected to commence as soon as possible thereafter in psoriasis patients."

The RNS says it was the best option available - " the Facility is the best option available to the Company at the present time".

To all those who have got something they would like to say, there is a "Post Message" button.

Use it and speak up!

AB,

If its so obvious, then what does it matter if its said or not?

Mountain out of a molehill me thinks. Try see the glass half full sometimes.

AB,

As CEO it's her job to have a plan B, C etc. Would be negligent if she didn't.

I just saw this on twitter. You can now register on Investor Meet Company to view Scancell investor meetings. They will presumably do their AGM's etc via this so we won't need to rely on private recordings! (Thanks again Botski).

Another sign of a more professional, business orientated approach by the company.

https://twitter.com/InvestorMeetCo/status/1678062432080592898?t=5YuNTUONL03rgQXWOph1WQ&s=19

Scancell's tweet with a link to Lindy's interview.

https://twitter.com/scancellpharma/status/1670751935362727936?t=Ar_HeDKKB3fcwIjQDmVqYw&s=19

It's not comparing apples with apples though. AZ have paid $85m upfront to partner with Quell for their entire (small) portfolio. Scancell licenced one pre-clinical antibody....

Violindog,

"Moditope's not looking too great". To who? Scancell certainly seem happy enough to present the data they have. Prof. Ottensmeier seems happy to present the data. The SP spiked massively on the first news too. Impatience seems to be the issue here.

TF,

You have to copy and paste the link in a browser. They seem to have changed the website a bit last weekend.

Any data that's released would be meaningful. However releasing data once does not a pattern make. All we can do is wait until Scancell decide to release data when they think its appropriate.

Yawn.

AB,
Regarding funding, the CEO's words at the AGM were - "The cash runway extends to Q1 2024. We will need to do deals, and further things, to extend beyond that".
That's a slightly different perspective to "obtaining funding".

There you have it from SOG Ahfam. It really sucks when facts don't correspond with your narrative.

So from the guidelines I posted below, approval should be anytime between April 21st and June 28th.
You point is Ahfam......

May have to wait a couple of months if that red dot is about 1801.
"Approval time for clinical trials in Australia
Human Research Ethics Committee (HREC) review takes 1-3 months (however, it depends upon the institution), and CTN review takes about 7–14 days."

It is coincidentally unfortunate. It's really close to LPH too. Unfortunate coincidences indeed.

PH,
Why do you assume everyone here is male?

Hi SOG,
Scroll down to the Bull/Bear hypotheses. It's the first point under Bear.

Bert,
I was surprised to see "turned down". Its my belief that "delayed" is more appropriate. Moot point now though.